Search results
Results from the WOW.Com Content Network
Intuitive is a big player in the surgical robots market, which Grand View Research projects will increase at a compounded annual growth rate of 9.5% until 2030.
Intuitive Surgical is best known for the da Vinci system, a robotic-assisted surgery (RAS) device that allows physicians to perform various procedures, from kidney removals to hernia repairs.
For the fiscal year 2017, Intuitive Surgical reported earnings of US$660 million, with an annual revenue of US$3.129 billion, an increase of 15.7% over the previous fiscal cycle. Intuitive Surgical's shares traded at over $307 per share, and its market capitalization was valued at over US$58 billion in November 2018. [10]
Intuitive Surgical has become one of the most debated stories in the health-care industry in recent weeks. In addition to negative reports from the investment and medical communities in recent ...
Piper Sandler maintains Intuitive Surgical with an Overweight, raising the price target from $490 to $495. Stifel maintains Intuitive with a Buy rating, raising the price target from $430 to $475.
The agreement gave Intuitive Surgical an equity stake in Hansen and royalties on the future sales of Hansen Medical products. The full financial terms of the agreement were not made public. [3] Hansen Medical went public in 2006, raising $75 million in its initial public offering with two catheter systems under FDA review. The shares ...
Intuitive Surgical -- maker of the daVinci Robotic Surgical System -- and its investors have experienced quite the roller coaster over the past year. From medical professionals publicly ...
For premium support please call: 800-290-4726 more ways to reach us